The Acquirers Podcast cover image

Andrew Summers of Summers Value Partners on healthcare, biotech $GILD, $QURE and $ELMD | S08 E02

The Acquirers Podcast

00:00

Unicure and Huntington's Drug Hurdle

Andrew explains Unicure's AMT-130 data, FDA pushback on historical controls, and likely pressure for a regulatory path forward.

Play episode from 57:14
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app